NCT05212064View on ClinicalTrials.gov

HFNC and Hypoxia/Desaturation During Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical Trial

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

August 17, 2023

Study Completion Date

August 17, 2023

Conditions

PropofolHypoxiaSedation ComplicationDesaturation of Blood

Interventions

DEVICE

high-flow oxygen nasal cannula therapy

Heated and humidified oxygen of 40L/minute through high-flow nasal cannula (HFNC) therapy machine.

OTHER

nasal cannula oxygen therapy

Heated and humidified oxygen of 6L/minute through high-flow nasal cannula (HFNC) therapy machine.

Trial Locations (1)

310000

Zhejiang Cancer hospital, Hangzhou

All Listed Sponsors

lead

Zhejiang Cancer Hospital

OTHER

NCT05212064 - HFNC and Hypoxia/Desaturation During Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical Trial | Biotech Hunter | Biotech Hunter